[1] H. FUJIKI. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.[J]. Philosophia (Ramat-Gan, Israel), 1984, 7 1: 866-870. DOI:
10.20772/cancersci1959.75.10\_866[2] JARI HEIKKILÄ Karl E O Å. (−)-Indolactam V activates protein kinase C and induces changes in muscarinic receptor functions in SH-SY5Y human neuroblastoma cells[J]. Biochemical and biophysical research communications, 1989, 162 3: Pages 1207-1213. DOI:
10.1016/0006-291x(89)90802-4[3] SHUIBING CHEN. A small molecule that directs differentiation of human ESCs into the pancreatic lineage[J]. Nature chemical biology, 2009, 5 4: 258-265. DOI:
10.1038/nchembio.154[4] T THATAVA. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny[J]. Gene Therapy, 2010, 18 3: 283-293. DOI:
10.1038/gt.2010.145[5] AVI RAVEH. Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts.[J]. Molecular Pharmacology, 2014, 86 4: 406-416. DOI:
10.1124/mol.114.092403